Analyst Recommendations
5.44 -0.75(-12.12%)09/16/2024
Black Diamond Therapeutics Inc (BDTX)
Black Diamond Therapeutics Inc (BDTX)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 4 |
Outperform | 4 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades